DyaMX
Plymouth, US · Founded 2017 · Delaware corporation
Founders & leadership
RK
ROBERT KUKUJLANExecutive
PH
PAUL HINDRICHSExecutive
Board
JB
JULIET BAKKERBoard director
JE
JAMES EADIEBoard director
JD
JOHN DEEDRICKBoard director
Reported raises · per SEC filings
Form D private placements$122M disclosed across 6 rounds · 2018–2024
▶$69.6MraisedJun 2024 · 11 investors · Other Health CareRule 506(b)
▶$69.6MraisedJun 2024 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gerald BrunkDirector
- Stacey PughExecutive Officer, Director
- Jeffrey TerrellDirector
- Juliet BakkerDirector
- James EadieDirector
- Offering amount
- $89.6M
- Amount sold
- $69.6M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.3MraisedOct 2023 · 9 investors · Other Health CareRule 506(b)
▶$18.3MraisedOct 2023 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Juliet BakkerDirector
- Gerald BrunkDirector
- Stacey PughExecutive Officer, Director
- James Eadie, M.D.Director
- Jeffrey TerrellDirector
- John DeedrickDirector
- Offering amount
- $18.3M
- Amount sold
- $18.3M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.2MraisedFeb 2023 · 7 investors · Other Health CareRule 506(b)
▶$9.2MraisedFeb 2023 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Juliet BakkerDirector
- Stacey PughExecutive Officer, Director
- James Eadie, M.D.Director
- John DeedrickDirector
- Offering amount
- $13M
- Amount sold
- $9.2M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12MraisedApr 2021 · 7 investors · Other Health CareRule 506(c)
▶$12MraisedApr 2021 · 7 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- ROBERT KUKUJLANExecutive Officer
- PAUL HINDRICHSExecutive Officer, Director
- JULIET BAKKERDirector
- JAMES EADIEDirector
- JOHN DEEDRICKDirector
- Offering amount
- $12M
- Amount sold
- $12M
- Minimum investment
- $37.9K
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06c
▶$12.8MraisedDec 2018 · 6 investors · Other Health CareRule 506(c)
▶$12.8MraisedDec 2018 · 6 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Juliet BakkerDirector
- John DeedrickExecutive Officer, Director
- Robert KukuljanExecutive Officer
- James EadieDirector
- Michael BrenzelExecutive Officer
- Paul HindrichsExecutive Officer, Director
- Offering amount
- $12.8M
- Amount sold
- $12.8M
- Minimum investment
- $42.5K
- Proceeds to insiders
- $525K
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06c
▶$140KraisedFeb 2018 · 6 investors · Other Health CareRule 506(c)
▶$140KraisedFeb 2018 · 6 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Paul HindrichsExecutive Officer, Director
- John DeedrickExecutive Officer, Director
- Robert KukuljanExecutive Officer
- Offering amount
- $1M
- Amount sold
- $140K
- Minimum investment
- $5K
- Proceeds to insiders
- $30K
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has DyaMX raised?
- DyaMX has disclosed $122M raised across 6 rounds.
- Where is DyaMX headquartered?
- DyaMX is headquartered in Plymouth, US.